home / stock / knte / knte quote
Last: | $2.65 |
---|---|
Change Percent: | 0.38% |
Open: | $2.64 |
Close: | $2.65 |
High: | $2.675 |
Low: | $2.64 |
Volume: | 2,812,224 |
Last Trade Date Time: | 04/02/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$2.65 | $2.64 | $2.65 | $2.675 | $2.64 | 2,812,224 | 04-02-2024 |
$2.66 | $2.65 | $2.66 | $2.67 | $2.64 | 862,362 | 04-01-2024 |
$2.66 | $2.66 | $2.66 | $2.69 | $2.65 | 518,478 | 03-29-2024 |
$2.66 | $2.66 | $2.66 | $2.69 | $2.65 | 518,478 | 03-28-2024 |
$2.66 | $2.64 | $2.66 | $2.675 | $2.64 | 472,324 | 03-27-2024 |
$2.63 | $2.66 | $2.63 | $2.66 | $2.63 | 714,882 | 03-26-2024 |
$2.65 | $2.65 | $2.65 | $2.6784 | $2.64 | 340,709 | 03-25-2024 |
$2.65 | $2.65 | $2.65 | $2.6613 | $2.63 | 1,770,785 | 03-22-2024 |
$2.65 | $2.65 | $2.65 | $2.675 | $2.63 | 755,215 | 03-21-2024 |
$2.65 | $2.64 | $2.65 | $2.66 | $2.635 | 1,016,890 | 03-20-2024 |
$2.55 | $2.55 | $2.55 | $2.57 | $2.54 | 167,607 | 03-19-2024 |
$2.55 | $2.55 | $2.55 | $2.57 | $2.54 | 170,565 | 03-18-2024 |
$2.56 | $2.53 | $2.56 | $2.56 | $2.53 | 254,203 | 03-15-2024 |
$2.53 | $2.55 | $2.53 | $2.55 | $2.52 | 154,125 | 03-14-2024 |
$2.54 | $2.55 | $2.54 | $2.57 | $2.53 | 329,261 | 03-13-2024 |
$2.55 | $2.56 | $2.55 | $2.56 | $2.53 | 349,581 | 03-12-2024 |
$2.54 | $2.57 | $2.54 | $2.58 | $2.54 | 692,529 | 03-11-2024 |
$2.58 | $2.58 | $2.58 | $2.6 | $2.57 | 153,843 | 03-08-2024 |
$2.565 | $2.59 | $2.565 | $2.6012 | $2.56 | 227,052 | 03-07-2024 |
$2.57 | $2.6 | $2.57 | $2.6 | $2.57 | 74,668 | 03-06-2024 |
News, Short Squeeze, Breakout and More Instantly...
Kinnate Biopharma Inc. Company Name:
KNTE Stock Symbol:
NASDAQ Market:
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...
EMERYVILLE, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ:XOMA) ("XOMA" or the "Company"), a biotechnology royalty aggrega...
EMERYVILLE, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA) (“XOMA” or the “Company”), a biotechnology royalty aggregator playing a distinctive role in helping biotech companies achieve their goal of improving human health, today announced th...